p38 MAPK, microglial signaling, and neuropathic pain
2007

The Role of p38 MAPK in Microglial Signaling and Neuropathic Pain

publication Evidence: moderate

Author Information

Author(s): Ji Ru-Rong, Suter Marc R

Primary Institution: Brigham and Women's Hospital and Harvard Medical School

Hypothesis

p38 MAPK activation in spinal microglia contributes to the development and maintenance of neuropathic pain.

Conclusion

p38 MAPK plays a critical role in microglial signaling under neuropathic pain conditions and represents a valuable therapeutic target for pain management.

Supporting Evidence

  • Microglia are a main source of inflammatory mediators in the CNS.
  • p38 MAPK is activated in spinal microglia after nerve injury.
  • Blocking p38 MAPK can prevent the development of neuropathic pain symptoms.
  • Microglial activation is crucial for the early development of neuropathic pain.
  • Different types of nerve injuries induce complement cascade in spinal microglia.

Takeaway

When nerves get hurt, special brain cells called microglia become active and can cause pain. A protein called p38 MAPK helps these cells send out signals that make the pain worse.

Methodology

The study reviewed existing evidence on p38 MAPK activation in spinal microglia after nerve injury and its role in neuropathic pain.

Limitations

The study primarily reviews existing literature and does not present new experimental data.

Digital Object Identifier (DOI)

10.1186/1744-8069-3-33

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication